Biological Software: Why the Pharma Industry Needs to Recode it's DNA

The pharmaceutical industry has long treated biology as chemistry, but a new generation of scientists is learning to read and write it as code. From AI-designed proteins to programmable cell therapies, biological software is collapsing the boundary between computation and medicine. This session explores what it means to build drugs the way engineers build software, and what Europe must do to lead the revolution rather than license it.